SCHEMBL12892067

SCHEMBL12892067

CCCc1ccc(Br)cc1/C=C1\SC(=S)NC1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTP4A3 O75365 6/20 0.65
▸ CISD1 Q9NZ45 3/20 0.56
▸ NAT1 P18440 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ HTT P42858 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ TP53 P04637 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ PSMD14 O00487 2/20 0.49
▸ POLB P06746 2/20 0.49
▸ MMP2 P08253 2/20 0.49
▸ RECQL P46063 2/20 0.49
▸ MYC P01106 1/20 0.49
▸ MAX P61244 1/20 0.49
▸ ALPL P05186 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14529265 0.86 NAT1 (0.59) PTP4A3NAT1MEN1MAPTKMT2A
SCHEMBL14463961 0.84 PTP4A3 (0.64) PTP4A3CISD1NAT1NPC1RAB9A
SCHEMBL10090318 0.82 PTP4A3 (0.53) PTP4A3CISD1NAT1MEN1MAPT
SCHEMBL14464046 0.82 PTP4A3 (0.71) PTP4A3CISD1NAT1MEN1MAPT
SCHEMBL13499558 0.79 PTP4A3 (0.71) PTP4A3CISD1NAT1MYCMAX
SCHEMBL14464056 0.79 PTP4A3 (1.00) PTP4A3CISD1NAT1MYCMAX
SCHEMBL14463959 0.79 PTP4A3 (0.71) PTP4A3CISD1NAT1MEN1MAPT
SCHEMBL10090151 0.77 PTP4A3 (0.69) PTP4A3CISD1NAT1MEN1MAPT
SCHEMBL13499559 0.76 PTP4A3 (0.67) PTP4A3CISD1NAT1MYCMAX
SCHEMBL2066304 0.76 PTP4A3 (0.68) PTP4A3CISD1NAT1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879893-B2 Zinc binding ligand; sustained release of insulin NOVO NORDISK A/S (DK) 2011-02-01 — — US disclosed
US-7879893-B2 Zinc binding ligand; sustained release of insulin NOVO NORDISK A/S (DK) 2011-02-01 — — US disclosed
EP-1585541-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING INSULIN AND LEGENDS OF INSULIN HEXAMER NOVO NORDISK AS (DK) 2007-11-14 — — EP disclosed
Send feedback